Related Experiment Video
Updated: Jul 8, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Autonomously functioning thyroid nodule associated with thyrotoxic periodic paralysis.
Hiroshi Ozaki1, Kouki Mori, Yoshinori Nakagawa
1Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Endocrine Journal
|January 19, 2008
Summary
Thyrotoxic periodic paralysis (TPP) is rarely linked to autonomously functioning thyroid nodules (AFTN). This case shows TPP resolved after AFTN treatment, suggesting different genetic causes than familial periodic paralysis.
Area of Science:
- Endocrinology
- Genetics
- Molecular Biology
Background:
- Thyrotoxic periodic paralysis (TPP) is a rare neuromuscular disorder.
- It is primarily associated with Graves' disease, but can also occur with autonomously functioning thyroid nodules (AFTN).
- The genetic underpinnings of TPP, especially in AFTN cases, are not fully understood.
Observation:
- This report details a patient with AFTN who also experienced TPP.
- The TPP symptoms resolved following radioactive iodine ((131)I) therapy for the AFTN.
- Genetic analysis excluded known mutations in TSHR, Gsalpha, CACNA1S, and KCNE3 genes.
Findings:
- The case suggests that TPP associated with AFTN may have a distinct pathophysiology from familial hypokalemic periodic paralysis.
- Known genetic mutations in TSHR and Gsalpha appear less common in Japanese patients with AFTN-associated TPP.
- Resolution of TPP after AFTN treatment highlights the link between thyroid status and neuromuscular function.
Implications:
- This case expands the known clinical spectrum of AFTN.
- It suggests that genetic testing for familial periodic paralysis may not be relevant for TPP in AFTN patients.
- Further research into the molecular mechanisms of TPP in AFTN is warranted, particularly in diverse populations.
Related Concept Videos
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...